Coronary Heart Disease and Risk Factors in Latin America  by Lanas, Fernando et al.
REVIEW gREVIEWj
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Latin America
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Temuco, and Santiago, ChileABSTRACT
Cardiovascular diseases are the leading cause of death in Latin America, with ischemic heart disease as the
principal cause in most countries. Risk factors for cardiovascular disease are highly prevalent in the region,
but there are international variations in the pattern and level of risk factors. Overweight and obesity are
increasing. In the 2012 Mexican National Survey, overweight or obesity was found in 64.9% of men and
73% of women, and they were strongly associated with sedentarism. The most characteristic dyslipidemia
abnormality in the region is low high-density lipoprotein cholesterol, followed by elevated low-density
lipoprotein cholesterol and increased levels of triglycerides. National diabetes mellitus prevalence ranges
from 2.8% to 9.4% and tobacco smoking from 12.8% to 42%. According to the INTERHEART (A Study
of Risk Factors for First Myocardial Infarction in 52 Countries and Over 27,000 Subjects) data for Latin
America, the highest attributable risks for myocardial infarction were related to abdominal obesity,
dyslipidemia, and smoking.The authors report no re-
lationships that could be
construed as a conﬂict ofCardiovascular diseases (CVD) are the leading causes
of death in the Americas, accounting for 33.7% of total
mortality rates, with higher mortality values in Guyana,
Trinidad and Tobago, and Venezuela, whereas Canada,
Puerto Rico, and Chile exhibit the lowest values [1].
Within CVD, ischemic heart disease is the predominant
form, with an adjusted mortality of 66.4 per 100,000
persons in Latin America and the Caribbean [2]. It is highly
anticipated that this trend will continue due to population
aging and the adoption of Western lifestyles that lead to
increased sedentarism and obesity. These factors in turn
contribute to increased rates of hypertension, dyslipidemia,
and diabetes mellitus (DM) [3]. The objective of this paper
is to review evidence about the major risk factors under-
lying ischemic heart disease in Latin America.interest.
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HEART DISEASE IN LATIN AMERICA
Causal factors of acute myocardial infarction (AMI) were
analyzed in Latin America as well as worldwide by the
INTERHEART (A Study of Risk Factors for First Myocar-
dial Infarction in 52 Countries and Over 27,000 Subjects)
[4,5]. This study analyzed 15,152 cases of ﬁrst AMI
patients and 14,820 control subjects from 52 countries, of
which 1,237 cases and 1,888 control subjects were from 6
Latin American countries (Argentina, Brazil, Colombia,
Chile, Guatemala, and Mexico). Worldwide factors asso-
ciated with AMI were dyslipidemia, smoking, psychosocial
factors (such as depression and stress), hypertension, DM,
abdominal obesity, and protective factors such as physical
activity, diet rich in fruits and vegetables, and moderate
consumption of alcohol.GLOBAL HEART, VOL. 8, NO. 4, 2013
December 2013: 341-348In Latin American INTERHEART countries, former or
current tobacco smoking, elevated waist/hip ratio, and
apolipoprotein (apo) B/apo A-1 ratios were the most
prevalent factors in control subjects. The strongest associ-
ation with AMI, with an odds ratio (OR) of 2.8, corre-
sponded to a history of hypertension and permanent stress.
Periods of psychological stress were reported by 17% of
control subjects and in 24.7% of cases, with an OR of 2.0
(95% conﬁdence interval [CI]: 1.6 to 2.6, p < 0.0001).
Daily consumption of fruits and/or vegetables and regular
exercise had a protective effect, with an OR of 0.6 (95% CI:
0.5 to 0.8) and 0.7 (95% CI: 0.6 to 0.8), respectively
(Table 1). No signiﬁcant associations with socioeconomic
status (i.e., education and income level), depression, or
alcohol were seen. The combination of lack of daily con-
sumption of fruits and/or vegetables and regular exercise
together had an OR of 63 (95% CI: 23.7 to 168.0).
There were 2 previous Latin American publications
devoted to quantifying the degree of association of risk
factors with AMI. One study conducted in Argentina,
Cuba, Mexico, and Venezuela reported an independent
association between AMI and the following risk factors:
total cholesterol; hypertension; smoking; and diabetes [6].
Unlike in INTERHEART, there were wide differences be-
tween countries. The second study, which was carried out
in Brazil, reported associations of AMI and the following
risk factors: smoking; high blood sugar levels; history of
diabetes; waist/hip ratio; family history of heart disease;
low-density lipoprotein cholesterol; and hypertension.
Alcohol consumption had a signiﬁcant protective effect [7].
Despite some differences, the 3 cited studies revealed that
known, easily measurable, and controllable risk factors are
responsible for most AMI in Latin America. Regional341
TABLE 1. INTERHEART Latin America: Prevalence of risk factors in the control group, OR, and PAR for male and female subjects
combined
Risk factor
Prevalence in control
subjects (%) OR (95% CI) PAR (95% CI)
Apo B/Apo A-1* 42.0 2.3 (1.8e9.4) 40.8 (30.3e52.2)
Tobaccoy 48.1 2.3 (2.0e2.7) 38.4 (32.8e44.4)
Diabetes mellitus 9.54 2.6 (2.1e3.2) 12.9 (10.3e16.1)
Arterial hypertension 29.1 2.8 (2.4e3.3) 32.9 (28.7e37.5)
Waist/hip ratio 48.6 2.5 (2.0e3.1) 45.8 (35.8e56.2)
Depression 28.9 1.2 (1.0e1.4) 4.7 (1.4e13.9)
Permanent stressz 6.8 2.8 (2.1e3.8) 28.1 (18.5e40.3)
Regular exercise 22.0 0.7 (0.6e0.8) 28.0 (17.7e41.3)
Alcohol 19.4 1.1 (0.9e1.3) 3.2 (18 to 11.7)
Daily consumption of fruit or vegetables 85.0 0.7 (0.6e0.8) 6.9 (3.35e10.5)
N ¼ 3,125. Participant countries include the following: Argentina, Brazil, Colombia, Chile, Guatemala, and Mexico. For protective factors (diet,
exercise, and alcohol), PAR correspond to the group without these factors. apo, apolipoprotein; CI, conﬁdence interval(s); INTERHEART, A Study of
Risk Factors for First Myocardial Infarction in 52 Countries and Over 27,000 Subjects; OR, odds ratio(s); PAR, population-attributable risk.
*First versus third tertiles.
yNever versus active and former smokers.
zNever versus permanent.
Adapted with permission from Lanas et al. [5].
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and tobacco smoking will be analyzed here; arterial hy-
pertension will be reviewed in a separate publication.OBESITY
The World Health Organization (WHO) has deﬁned normal
weight as a body mass index (BMI) between 18.5 and 24.9
kg/m2, overweight as BMI between 25 and 29.9 kg/m2, and
obesity as BMI 30 kg/m2 [8]. Over recent decades, obesity
has become a global epidemic, representing a major cause of
disability and mortality [8,9]. It is estimated that by 2020,
obesity and overweight will account for 57% of the disease
burden worldwide [9]. Both obesity and overweight are
associated with an increase in overall mortality [9,10].
Obesity has been estimated to annually account for 280,000
to 325,000 deaths in the United States [9], with CVD
contributing signiﬁcantly to these obesity-attributable mor-
tality cases [8,11].
Although obesity is associated with other downstream
cardiovascular risk factors, such as DM and hypertension, it
is also an independent risk factor for CVD [12]. Body fat
distribution is also an important risk factor for obesity-
related health problems. Several studies have shown that
the presence of abdominal obesity has been linked to coro-
nary artery disease [4,13e15]. Even in coronary patients
with normal BMI, the presence of abdominal obesity is
directly associated with increased mortality [16,17].
Prevalence of obesity has reached alarming levels in some
countries. In the United States, an overweight and obese
population of 67% has been reported in adults 20 years
[18]. Population growth and social development in Latin
America has led to a demographic transition, increasing the
frequency of obesity occurrence, which greatly differs amongthe countries of the region [9,11,19,20].Over the last decades,
Brazil experienced increased consumptionof processed foods,
with a rise in fat intake, speciﬁcally saturated fat, along with
increased sodium and sugar intake [21]. This is likely a cause
of an increased obesity prevalence—14.8% in the population
>20 years in 2010—with the highest increase in both the
lowest income quintile and in less-educated women [21]. In
Mexico, the 2012 National Health Survey (NHS) revealed
alarming ﬁgures, with a prevalence of overweight and obesity
of 64.9% in men and 73% in women >20 years [22]. In
Colombia in 2007, an estimated 32.2% were overweight and
13.7% were obese between 18 and 69 years of age [23]. In
Argentina, 34.5% showed overweight and 14.6% obesity in
persons older than 17 years, with an increase directly related
to aging [24]. In Chile, prevalence rates of obesity reached
25.1% in persons older than 14 years, and theywere higher in
women, with a rate of 30.7% [25]. All of these prevalences are
inﬂuenced by national age distributions and are not stan-
dardized, which limits comparisons. In several countries, the
pattern of higher obesity occurring more in both lower so-
cioeconomic levels and lower levels of education is repeated
[22,24,25]. In the INTERHEART study, which was con-
ducted in Latin America, an increased waist/hip ratio was
associatedwith an increased risk of AMI,with anoverall ORof
2.5 (95%CI: 2.0 to 3.14) and a higher OR of 4.1 (95%CI: 2.6
to 6.5) in women. It was the most prevalent risk factor for this
population. This association was also higher than that found
for other INTERHEART regions studied [5].
Weight reduction in obese subjects reduces the incidence
of disease and various cardiovascular beneﬁts may be ach-
ieved [26]. Health promotion efforts in Latin America have
included nutrition and physical activity promotion pro-
grams, but further work is needed to control this epidemic
[21,23].GLOBAL HEART, VOL. 8, NO. 4, 2013
December 2013: 341-348
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PHYSICAL INACTIVITY
Physical activity is deﬁned as any bodily movement pro-
duced by skeletal muscles that result in energy expenditure
[27]. Physical inactivity is an independent risk factor for
AMI [4] and other cardiovascular conditions.
Physical exercise, when part of work and leisure-time
activities, has a beneﬁcial effect in the prevention of
ischemic heart disease, in lowering overall mortality, and in
improving quality of life [28]. Despite the known beneﬁts
of exercise, physical inactivity is common in the general
population. In 2009, reports on Latin America docu-
mented that only a 14.7% of the Brazilian population was
physically active [21]. In Uruguay, the National Survey of
Risk Factors reported that 35.1% of the population >25
years exhibit low levels of physical activity [29]. In
Venezuela, 70% of sedentarism has been documented in
metropolitan areas [30], whereas in Argentina an estimated
46.2% of the population has a low level of physical activity,
according to NHS 2005 [24]. In Chile, the 2009 to 2010
NHS documents a prevalence of multidimensional seden-
tarism of 27.1% and 88.6% of free-time sedentary activities
[25]. In Mexico, 17.4% of the adult population is consid-
ered physically inactive [22].
Prevalence is an indicator of the frequency of a risk
factor, and it is important to know by how much this
risk factor increases the occurrence of disease in a particular
population. In the INTERHEART study, the population-
attributable risk (PAR) of coronary heart disease due to
sedentary behavior in Latin America and the Caribbean was
7.1%, ranging from 2.7% in Guatemala to 11.3% in
Argentina, high levels when compared with 3.9% in Africa,
5.5% in Europe, and 3.2% in Southeast Asia. Additionally, it
is estimated that life expectancywould increase by 0.82 years
if the LatinAmerican populationwere to change its sedentary
lifestyle, thus becoming the region that would beneﬁt most
from increased levels of physical activity [31].
Considering how rare it is in contemporary pop-
ulations to have healthy levels of energy expenditure, it is
worth asking what the factors that promote sedentary
behavior are. These factors include those belonging to the
psychosocial and socioeconomic dimension and those
associated with the built environment [32]. Urbanization in
developing countries is often associated with poor urban,
social, environmental, and labor infrastructures [33], thus
hindering an active lifestyle because of increased mecha-
nization and reduced safety. Factors related to climatic and
seasonal conditions also lead to low average physical ac-
tivity levels in some populations.
Consequently, it is important to promote the message
that healthy adults ages 18 to 65 years need moderate-
intensity aerobic activity for at least 30 min, 5 a week, or
vigorous-intensity physical activity for at least 20 min, 3 a
week, along with activities that maintain or increase muscular
strength and endurance, 2 a week [34]. Although this may
look like a difﬁcult task, there are interventions that have
proven effective, for example, exercise sessions in healthGLOBAL HEART, VOL. 8, NO. 4, 2013
December 2013: 341-348centers, home sessions, group walks, telephone monitoring,
and incentives [35].DYSLIPIDEMIA
Hypercholesterolemia plays a predominant role in the
initiation and development of atherosclerotic lesions. A high
prevalence of dyslipidemia has been documented in various
NHS and national/regional cross-section studies. The most
common alteration is the presence of reduced levels of high-
density lipoprotein cholesterol (40 mg/d). Chile’s NHS
reported reduced levels of high-density lipoprotein choles-
terol in 48.4% of men and 30.6% of women [25]. Preva-
lences were 63.0% in Colombia [23], and 60.5% in Mexico
[22] in their respective NHS. In a study conducted in various
Peruvian cities, low high-density lipoprotein prevalence
rates were 40% in women and 38% in men [36]; these
values are substantially higher than those observed in the
United States (i.e.,18.9%) [37]. The secondmost commonly
encountered dyslipidemic condition is high low-density
lipoprotein cholesterol levels (200 mg/dl). In Mexico, the
NHS reported a prevalence of 43.6% [22], whereas in Chile,
38.5% of men and 39% of women were documented [25].
The Chilean survey also revealed levels >240 mg/dl in
11.6% of the population; these results are similar to those
observed in Colombia [8%], but lower than those observed
in the United States (i.e., 15%) [37]. In Brazil, total choles-
terol levels >190 mg/dl were found in 22% of adults and
one-third of those were adults >45 years living in cities
with more than 100,000 inhabitants [21]. High triglyceride
levels constitute the third most frequent abnormality. The
MexicanNHS registered hypertriglyceridemia (150mg/dl)
in 31.5% of the respondents, whereas in Chile, it was
found in 31%, with 17% of individuals with triglycerides
>200 mg/dl.
Differences in the prevalence of dyslipidemia between
cities are commonly encountered in the countries of Latin
America. For example, Bogotá has a high prevalence,
whereas the Atlantic, Paciﬁc, Orinoquian, and Amazonian
regions in Colombia exhibit signiﬁcantly lower prevalence
[23]. A high percentage of people in Latin America do not
know their blood lipid levels; only about one-half of adults
in the Argentinian NHS reported to have undergone
cholesterol screenings [24]. Cholesterol testing was more
frequently performed in capital cities and was closely
related to individual higher socioeconomic or educational
levels, unlike the NHS in Spain, which reports that 87.3%
of people ages 35 to 74 years had their cholesterol
measured in the last 5 years [38]. In Mexico, only 8.6% of
patients with elevated cholesterol knew their diagnosis
[23], whereas in Chile about 18.8% of the population was
reported to have been diagnosed with high cholesterol by a
physician, nurse, or other health professional [26]. In the
CARMELA (Cardiovascular Risk Factor Multiple Evalua-
tion in Latin America) study, which included 11,550
people ages 25 to 64 years, who lived in 7 Latin American343
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cholesterolemia was relatively low (41%). Eighty-eight
percent of the subjects were not under treatment and
among those receiving drug therapy, only 52% had ach-
ieved the proposed targets [39].DIABETES MELLITUS
Diabetes mellitus prevalence has been increasing over
recent decades, and it is associated with changes in diet,
an increase in obesity, and a sedentary lifestyle. It has
reached epidemic levels worldwide, with prevalence be-
tween 5% and 19%, depending on the population studied
[20,40e45]. In 2010, it was estimated that 18.8 million
people in the United States had been diagnosed with DM
and about 7 million had undiagnosed diabetes [46]. Its
frequency increases in relation to age and BMI, which is
lower in subjects with higher income and educational
levels [45]. A notorious increase in child and adolescent
diabetes, closely associated with lifestyle changes, has been
observed lately. In some population groups, the prevalence
of diabetes is particularly high, as in the case of Latin
subjects living in the United States (age-adjusted preva-
lence: 16.7% in men and 17.2% in women), with differ-
ences depending on geographic origin: 10.1% in those of
South American origin; and 19.3% in those of Mexican
origin [47]. In Latin America, the overall estimated prev-
alence of diabetes is 5%, much lower than that of Latin
subjects living in the United States, which reﬂects the
importance of lifestyle in the development of this disease
[42,46]. However, differences have been observed among
the Latin American countries. Chile, with a national
prevalence of 9.4% in the population >14 years, is part of
the group of countries exhibiting high frequency of DM,
and prevalence is particularly higher in women [25]. In
Mexico, in 2012, diabetes was found in 9.2% of the pop-
ulation >20 years, showing a signiﬁcant increase compared
with ﬁndings reported in previous years [22]. In Argentina,
8.5% of the population >18 years reported diabetes or
high glucose levels [24]. Brazil was found to be at an in-
termediate level, with a self-reported diabetes frequency of
5.3% in those >20 years [21]. Nevertheless, previous
studies applying glucose tolerance test in addition to the
report, reported diabetes in 7.6% of the study population
[21]. Colombia and Peru are among countries with the
lowest diabetes prevalence rates. Colombia exhibited a
presence of self-reported diabetes of 3.5% in individuals
between 18 and 69 years [23], whereas Peru reported an
estimated diabetes rate of 2.8% in 2006 in the population
>20 years [48]. The presence of DM in Latin America is
more common in less-educated subjects [22,24,25]. DM
prevalence in Chile in the group with <8 years of
schooling reached 20% [25].
Diabetes is a well-known cardiovascular risk factor that
increases event incidence rates by 2 to 3, independent
of other risk factors [49]. The main causes of death in
patients with diabetes are CVD, accounting for 44% ofdeaths in those with type 1 DM and 52% in those with type
2 DM [50]. Mortality due to CVD associated with DM is
higher in women than in men, with a relative risk of 2.6
(95% CI: 2.1 to 3.3) versus 1.9 (95% CI: 1.5 to 2.3, p ¼
0.045), respectively [51]. The INTERHEART study
demonstrated that diabetes is a risk factor of AMI in Latin
America, with an OR of 2.6 (95% CI: 2.1 to 3.2) and PAR
of 12.9 (95% CI: 10.3 to 16.1), which is similar to that
found in other regions studied. An increased association of
diabetes with infarction in women was reported, with a
signiﬁcant PAR greater than that found for men [5]. In
many Latin American countries, healthy eating, promotion
of physical activity, and lifestyle change programs have
been implemented [21,23,25]. This is a signiﬁcant effort,
because these behavioral changes have proved effective in
preventing the development of diabetes [52e55].TOBACCO SMOKING
Tobacco smoking has been shown to cause a variety of
diseases and accounts for 50% of preventable deaths in
smokers, one-half of them due to cardiovascular disease.
The harmful effects of tobacco smoke in active and former
smokers are directly related to the amount of cigarettes
smoked per day as well as to smoking duration. Moreover,
evidence has shown that passive smokers are also at
increased risk levels of an adverse health outcome. For
instance, a woman exposed to spousal smoking is 30%
more likely to experience a cardiovascular event, which is
the same health risk experienced by those exposed to
workplace passive smoking [56].
Despite the known harmful effects of tobacco smoking
and the various smoke-free campaigns and policies that have
been implemented in different regions of theworld, smoking
prevalence is still unacceptably high. According to Latin
American reports, prevalence rates of smoking (deﬁned as
having smoked >100 cigarettes and currently smoking)
range from 12.8% in Colombia [23], 15.5% in Brazil [21],
and 19.9% in Mexico [22], up to 32.7% and 33.4% in
Uruguay [33] and Argentina [24], respectively, and as high
as 42% in Chile [25]. Nevertheless, a slight decrease in rates
over the years in Latin America has been documented.
In all countries, smoking prevalence is higher among
men than among women, a gap that has narrowed over the
years. It is noteworthy that the health risk associated with
smoking is proportionally higher in women, especially if
they are taking oral contraceptives [56]. A slight association
between tobacco smoking and socioeconomic and educa-
tional status has been observed.
The beneﬁts of smoking cessation have been widely
studied. Several interventions for smoking cessation, both
individually and at the population level have already been
implemented. In an individual context, motivation and
professional assistance appear as vital factors to be taken
into account. Any intervention is more successful if carried
out at the time of diagnosis of an associated disease or
when other therapeutic interventions are being carried outGLOBAL HEART, VOL. 8, NO. 4, 2013
December 2013: 341-348
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(such as angioplasty or coronary bypass). Within individ-
ual interventions, the nonpharmacological strategies, such
as individual or group behavioral interventions [57,58],
along with drug treatments, such as nicotine replacement
therapy, varenicline, and bupropion [59], have to be cited.
At the population level, the WHO Framework
Convention on Tobacco Control should be highlighted. It
incorporates 2 types of measures: 1) measures related to
the reduction of demand for tobacco (including actions
over prices and taxes, and others such as protection fromTABLE 2. Countries in Latin America that have ratiﬁed, or signed, the
are being implemented
Countries that have ratiﬁed the WHO FCTC Articl
Antigua and Barbuda None
Argentina* Ad valorem
Bahamas Ad valorem
Barbados Speciﬁc excise
Belize Speciﬁc excise
Bolivia Ad valorem
Brazil Speciﬁc excise
Chile Ad valorem
Colombia Speciﬁc excise,
Costa Rica Ad valorem
Cuba* Not available
Dominica Speciﬁc excise
Ecuador Ad valorem
El Salvador* Speciﬁc excise,
Grenada Ad valorem
Guatemala Ad valorem
Guyana Ad valorem
Haiti* Without inform
Honduras Speciﬁc excise
Jamaica Speciﬁc excise
Mexico Speciﬁc excise,
Nicaragua Speciﬁc excise
Panama Ad valorem
Paraguay Ad valorem
Peru Speciﬁc excise,
Saint Kitts and Nevis Ad valorem
Saint Lucia None
Saint Vincent and the Grenadines Speciﬁc excise
Suriname Speciﬁc excise
Trinidad and Tobago Speciﬁc excise
Uruguay Speciﬁc excise
Venezuela Ad valorem
Article 6: Prices and taxes. Article 8: Smoke-free environments: number (of
environments: health-care facilities, educational facilities except universities
transportation. Article 11: Health warnings (speciﬁc warnings mandated by
(of 13 possible) of media (national TV and radio, international TV and rad
paper, billboard and out-door advertising, point of sale, Internet) or forms
means, promotional discounts, nontobacco products identiﬁed with tobacc
products, appearance of tobacco products in TV or ﬁlm, tobacco-sponsored
Health Organization.
*Countries that have signature only.
GLOBAL HEART, VOL. 8, NO. 4, 2013
December 2013: 341-348exposure to tobacco smoke and packaging and labeling of
tobacco products); and 2) measures related to the reduc-
tion of tobacco supply (such as control of illegal trade in
tobacco products and sales to and by minors) [60]. As of
October 2010, the most signiﬁcant achievements in Latin
America have been observed in the implementation of
Articles 11 and 8 [61]. The Tobacco Control Report for
the Region of the Americas shows that 28 countries
have ratiﬁed the Framework Convention on Tobacco
Control and only 4 have signed it. Table 2 shows theconvention and how the principal measures for tobacco control
e 6 Article 8 Article 11 Article 13
1 No 0
7 Yes 9
0 Yes 1
8 No 0
0 No 0
4 Yes 5
1 Yes 7
3 Yes 9
ad valorem 8 Yes 13
1 Yes 0
4 Yes 0
0 No 0
8 Yes 10
ad valorem 8 Yes 13
0 No 0
8 Yes 1
3 Yes 0
ation 0 No 0
8 Yes 5
0 Yes 1
ad valorem 2 Yes 6
6 Yes 4
8 Yes 13
2 Yes 0
import duties 8 Yes 2
0 No 0
0 No 0
0 No 0
0 No 0
8 Yes 3
8 Yes 11
8 Yes 6
8 possible) of smoke-free environments established; type of smoke-free
, government facilities, indoor ofﬁces, restaurants, pubs and bars, public
law). Article 13: Bans of tobacco, promotion, and sponsorship: number
io, local magazines and newspaper, international magazines and news-
of direct and indirect advertisement (free distribution by mail or other
o brand names, brand names of nontobacco products used for tobacco
events). FCTC, Framework Convention on Tobacco Control; WHO,World
345
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346countries in Latin America that have ratiﬁed or signed the
convention and the implementations for the principal
measures (Table 2).DISCUSSION
The impact of a risk factor in the population depends on its
prevalence and the strength of association of the risk factor
with the disease outcome, measured by relative risk or OR.
In INTERHEART, the strength of association of risk factors
with AMI was similar in all regions of the world. Therefore,
it is mostly the differences in prevalence among regions
that explains differences in PAR. Prevalence of a risk factor
in the population is represented in INTERHEART, albeit
not precisely, by the prevalence in the control group.
Obesity has become a major health problem in Latin
America; it has reached prevalences over 25% inMexico and
Chile and near 15% in Argentina, Brazil, and Colombia. In
the INTERHEART study in Latin America, the highest PAR,
unlike that observed in the rest of the world, was due to
abdominal obesity: 45.8% (95%CI: 35.8 to 56.2). There was
a waist/hip ratio >0.95 in men and >0.90 in women in
46.8% of control subjects in Latin America and only in 33%
of those in other countries. In a systematic analysis of health
examination surveys worldwide, after standardizing for
population age structure, prevalence of obesity and over-
weight in Southern and Central Latin America were among
the highest in the world in 2008 [62].
Dyslipidemia, assessed by the apo B/apo A-1 ratio, had
the second place PAR in the region: 40.8% (95% CI: 30.3 to
52.2) in the INTERHEART study; prevalence of control
subjects in the upper quintile of apo B/apo A-1 ratio was
27.1% in Latin America, which is similar to that for South
East Asia, lower than that for the Middle Eastern countries,
but higher than that for all other regions of the study.Current
and former smoking was the third leading cause of AMI,
according to PAR: 38.4% (95% CI: 32.8 to 44.0). Important
differences in prevalence were observed in the region. The
lowest prevalences—below 20% in Colombia, Brazil, and
Mexico—were similar to those observed in North American
and some central African countries. Higher prevalences—
>30% in Argentina, Chile, and Uruguay—were similar to
those reported in the southern part of Europe and India. Still,
smoking prevalence in Latin American country sites was
lower than the smoking prevalence observed in Eastern
Europe, Russia, and China [63,64].
Priorities to reduce the burden of CVD in the Americas
have been deﬁned by Pan American Health Organization
and include the following: public policy and advocacy;
health promotion and disease prevention related to tobacco
use; harmful levels of salt intake; lack of healthy eating;
lack of physical activity; and alcohol use and integrated
control of noncommunicable diseases and their risk factors
with major emphasis on hypertension [65]. Among the
most-promising recent important steps taken by countries
in Latin America are the advances in tobacco control in
Uruguay. In March 2006, Uruguay became the ﬁrst LatinAmerican country to adopt a 100% smoke-free national
legislation. Two years after the smoke-free policy was enac-
ted, hospital admissions for AMI fell by 22% [66]. Another
advance was the provision of free access to medications for
hypertension and DM in Brazil since 2011 [67]. In Chile,
new laws guarantee health-care access and quality for all the
population with conditions such as DM, hypertension, AMI,
or stroke, which may be a factor in the reduction of in hos-
pital mortality in myocardial infarction [68].
SUMMARY
CVD risk factors are highly prevalent in Latin America.
Prevalence varies by sex, education, and socioeconomic
level. Amore intensive and integrated approach to individual
and population-level prevention is needed to reduce the
burden of CVD in the region. Lessons from recent advances
in CVD control in speciﬁc countries should be learned and
implemented by other countries in Latin America.
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